NewGenIvf Extends Reverse Merger Deadline to Finalize Agreement With EWIHL
NewGenIvf Extends Reverse Merger Deadline to Finalize Agreement With EWIHL
NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that both parties involved in the previously announced reverse merger with European Wellness Investment Holdings Limited ("EWIHL") have appointed legal counsel to prepare the Share Purchase Agreement (the "SPA"). Additionally, by mutual consent, the signing date for the SPA has been extended from January 27, 2025, to February 28, 2025. This extension will allow both parties sufficient time to complete the necessary due diligence, finalize the terms of the agreement, and ensure compliance with all relevant NASDAQ requirements for reverse mergers.
NewGenIvf集團有限公司（納斯達克:NIVF）（"NewGen"或"公司"）今天宣佈，先前宣佈與歐洲健康投資控股有限公司（"EWIHL"）的反向合併中，雙方都已聘請法律顧問準備股份購買協議（"SPA"）。此外，雙方經過共同同意，SPA的簽署日期已從2025年1月27日延長至2025年2月28日。此延長將爲雙方提供足夠的時間完成必要的盡職調查，最終確定協議條款，並確保遵守所有與反向合併相關的納斯達克要求。
This significant step follows the Company's prior announcement of a binding term sheet on December 11, 2024, which marked a pivotal moment in the Company's strategic partnership with EWIHL. This collaboration aims to leverage synergies between both companies to enhance service delivery and expand market reach in the healthcare sector.
這一重要步驟是公司在2024年12月11日之前宣佈的具有約束力的條款清單之後發生的，標誌着公司與EWIHL戰略合作關係的關鍵時刻。該合作旨在利用兩家公司之間的協同效應，以提升服務交付能力並擴大在醫療保健板塊的市場覆蓋。